Movano Inc. (NASDAQ:MOVE) Sees Significant Increase in Short Interest

Movano Inc. (NASDAQ:MOVE) was the target of a significant increase in short interest in January. As of January 30th, there was short interest totaling 105,116 shares, an increase of 313.2% from the January 15th total of 25,442 shares. Currently, 12.9% of the company’s stock are sold short. Based on an average daily volume of 5,519,052 shares, the short-interest ratio is currently 0.0 days. Based on an average daily volume of 5,519,052 shares, the short-interest ratio is currently 0.0 days. Currently, 12.9% of the company’s stock are sold short.

Movano Trading Down 6.4%

MOVE traded down $0.80 on Friday, reaching $11.69. The stock had a trading volume of 32,501 shares, compared to its average volume of 1,988,033. The business’s 50-day moving average price is $10.17 and its two-hundred day moving average price is $8.47. Movano has a 12-month low of $4.67 and a 12-month high of $54.40. The company has a market cap of $13.32 million, a P/E ratio of -1.08 and a beta of 0.81.

Movano (NASDAQ:MOVE) last announced its quarterly earnings results on Friday, November 14th. The technology company reported ($4.73) earnings per share for the quarter, beating the consensus estimate of ($7.00) by $2.27. The firm had revenue of $0.08 million during the quarter, compared to analyst estimates of $3.88 million. Movano had a negative return on equity of 647.91% and a negative net margin of 3,409.60%.

Insider Transactions at Movano

In other news, CTO Michael Aaron Leabman sold 6,845 shares of the stock in a transaction on Wednesday, January 14th. The stock was sold at an average price of $6.66, for a total transaction of $45,587.70. Following the completion of the sale, the chief technology officer owned 22,639 shares in the company, valued at approximately $150,775.74. This represents a 23.22% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Jeremy Cogan sold 28,736 shares of the business’s stock in a transaction on Tuesday, January 27th. The stock was sold at an average price of $20.78, for a total value of $597,134.08. Following the transaction, the chief financial officer owned 60,504 shares in the company, valued at approximately $1,257,273.12. This trade represents a 32.20% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 94,383 shares of company stock valued at $1,524,933. Corporate insiders own 10.40% of the company’s stock.

Institutional Investors Weigh In On Movano

A hedge fund recently bought a new stake in Movano stock. Citadel Advisors LLC purchased a new position in Movano Inc. (NASDAQ:MOVE) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned approximately 5.94% of Movano as of its most recent filing with the Securities and Exchange Commission. 16.64% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the stock. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Movano in a report on Thursday, January 22nd. Wall Street Zen raised shares of Movano from a “sell” rating to a “hold” rating in a report on Saturday, February 7th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has an average rating of “Sell”.

Key Headlines Impacting Movano

Here are the key news stories impacting Movano this week:

• Positive Sentiment: Macro/market uplift from company beats and upgrades — Airbnb saw Q4 revenue beat and an analyst upgrade, which can support risk appetite in consumer and growth names. Airbnb Stock Moves Higher As Q4 Sales Top Estimates, Deutsche Bank Lifts Rating To Buy
• Positive Sentiment: Biotech catalyst: Bristol‑Myers Squibb’s milvexian stroke trial advanced — positive for biotech sentiment and health‑tech investor risk appetite. BMY-Backed Milvexian Stroke Trial Moves Forward
• Neutral Sentiment: Energy supply update — natural gas supply fell but by less than traders expected, tempering a bullish energy move; mixed for broader inflation/energy narratives. Venezuelan Oil Is On The Move – The Energy Report
• Neutral Sentiment: Chip sector strength lifted on Micron CFO comments about HBM4 ramp — sector wins can buoy tech peers but don’t directly affect tiny med‑device names. Market Movers: Micron Soars on CFO Comments
• Negative Sentiment: Risk‑off headline: U.S. stocks moved sharply lower on AI disruption concerns and rotation worries — a broad market pullback pressures thin, speculative small caps like MOVE. U.S. Stocks Move Sharply Lower Amid AI Disruption Concerns
• Negative Sentiment: Crypto and risk assets under pressure — Ethereum and Bitcoin retests and weakness are contributing to wider risk‑off flows, which often hit micro‑caps hardest. Ethereum $1,900 Retest Could Decide Next Major Move – Is ETH Preparing For New Lows?

About Movano

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.